國立虎尾科技大學 |

Myelodysplastic syndromes = pathobiology and clinical management.

紀錄類型:	書目-語言資料,印刷品 : Monograph/item
正題名/作者:	Myelodysplastic syndromes/
其他題名:	pathobiology and clinical management.
其他作者:	Steensma, David P.
出版者:	New York, NY :Informa Healthcare, : c2009.,
面頁冊數:	1 online resource (ix, 541 p.) :ill. :
標題:	Myelodysplastic syndromes. -
電子資源:	Connect to Informa resource
ISBN:	1420074407 (electronic bk.)

Myelodysplastic syndromes = pathobiology and clinical management.
Myelodysplastic syndromespathobiology and clinical management.[electronic resource] : - 2nd ed. / - New York, NY :Informa Healthcare,c2009. - 1 online resource (ix, 541 p.) :ill. - Basic and clinical oncology ;36. - Basic and clinical oncology ;35.

Includes bibliographical references and index.

"Written by a team of leading authorities in pathogenesis, diagnostic techniques, and clinical management strategies in myelodysplastic syndrome (MDS), this text provides a concise, easy-to-follow review of the advances in the science, classification, diagnosis, and management of the condition. An ideal source for hematologists, oncologists, and cancer researchers, this Second Edition features: a new eight-page color insert: 200 color and black-and-white illustrations: and reworked content organized into three sections: MDS epidemiology and biology; diagnosis, classification, and prognosis; and MDS therapy thoroughly updated chapters reflecting a shift from the topical focus as dictated by the evolution of the field." "New topics in the Myelodysplastic Syndrome include: del(5q) and 5q-syndrome, CMML, and MDS-MPD overlap syndrome: the reborn DNA methyltransferase inhibiting nucleoside analogs : the diagnosis of chronic myelomonocytic leukemia and other MDS cases with myeloproliferative features: the role of mitochondria and the potential importance of iron overload in MDS: global genomics approaches, such as cDNA expression arrays, array-based comparative genomic hybridization, and single nucleotide polymorphism array:s the role of abnormal mitochondrial ferritin accumulation and other mitochondrial metabolic anomalies in MDS: other disease-associated alterations, such as abnormalities of B lymphocyte populations in MDS: and three recently approved drugs: azacitidine, lenalidomide, and decitabine"--Jacket.

ISBN: 1420074407 (electronic bk.)

DNLMSubjects--Topical Terms:

778458
Myelodysplastic syndromes.

LC Class. No.: RC645.73 / .M95 2009

Dewey Class. No.: 616.4/1

National Library of Medicine Call No.: W1 / BA813W v.36 2009

Myelodysplastic syndromes = pathobiology and clinical management.
LDR:02759cam a2200337 a 4500 001 684747
003 OCoLC
005 20111126202404.0
006 m d
007 cr zn|||||||||
008 111216s2009 nyua sb 001 0 eng d
016 7 $z 101481016 $2 DNLM
019 $a 313040605 $a 646791045
020 $a 1420074407 (electronic bk.)
020 $a 9781420074406 (electronic bk.)
020 $z 1420074393 (Cloth)
020 $z 9781420074390 (hardcover : alk. paper)
035 $a (OCoLC)317753772 $z (OCoLC)313040605 $z (OCoLC)646791045
035 $a ocn317753772
040 $a CDX $b eng $c CDX $d OCLCQ $d N $d IDEBK $d DKU $d E7B $d OCLCQ
050 0 0 $a RC645.73 $b .M95 2009
060 0 0 $a W1 $b BA813W v.36 2009
060 1 0 $a WH 380 $b M99593 2009
082 0 0 $a 616.4/1 $2 22
245 0 0 $a Myelodysplastic syndromes $h [electronic resource] : $b pathobiology and clinical management.
250 $a 2nd ed. / $b edited by David P. Steensma.
260 $a New York, NY : $b Informa Healthcare, $c c2009.
300 $a 1 online resource (ix, 541 p.) : $b ill.
490 1 $a Basic and clinical oncology ; $v 36
504 $a Includes bibliographical references and index.
520 1 $a "Written by a team of leading authorities in pathogenesis, diagnostic techniques, and clinical management strategies in myelodysplastic syndrome (MDS), this text provides a concise, easy-to-follow review of the advances in the science, classification, diagnosis, and management of the condition. An ideal source for hematologists, oncologists, and cancer researchers, this Second Edition features: a new eight-page color insert: 200 color and black-and-white illustrations: and reworked content organized into three sections: MDS epidemiology and biology; diagnosis, classification, and prognosis; and MDS therapy thoroughly updated chapters reflecting a shift from the topical focus as dictated by the evolution of the field." "New topics in the Myelodysplastic Syndrome include: del(5q) and 5q-syndrome, CMML, and MDS-MPD overlap syndrome: the reborn DNA methyltransferase inhibiting nucleoside analogs : the diagnosis of chronic myelomonocytic leukemia and other MDS cases with myeloproliferative features: the role of mitochondria and the potential importance of iron overload in MDS: global genomics approaches, such as cDNA expression arrays, array-based comparative genomic hybridization, and single nucleotide polymorphism array:s the role of abnormal mitochondrial ferritin accumulation and other mitochondrial metabolic anomalies in MDS: other disease-associated alterations, such as abnormalities of B lymphocyte populations in MDS: and three recently approved drugs: azacitidine, lenalidomide, and decitabine"--Jacket.
650 0 $a Myelodysplastic syndromes. $3 778458
650 1 2 $a Myelodysplastic Syndromes $x physiopathology. $3 778459
650 1 2 $a Myelodysplastic Syndromes $x therapy. $3 778460
700 1 $a Steensma, David P. $3 778457
830 0 $a Basic and clinical oncology ; $v 35 $3 778112
856 4 $z Connect to Informa resource $u http://informahealthcare.com/action/showBook?doi=10.3109%2F9781420074406